INTERAGENCY COMMITTEE ON RECOMBINANT DNA RESEARCH 
Minutes of Meeting 
February 25, 1977 
National Institutes of Health 
Bethesda, Maryland 
The third meeting of the full Interagency Committee took place on 
February 25th at the National Institutes of Health from 1:30 to 4:45 p.m. 
The meeting was chaired by Dr. Donald Fredrickson, Director of the NIH. 
Dr. Fredrickson stated that the purpose of this meeting was to review the 
work of the subcommittee to the Interagency Committee and to develop 
recommendations for the implementation of a common set of standards 
applicable to recombinant DNA research. 
Review of State/Local Activities 
In California, two legislative committees have held hearings and legislation 
may be proposed to regulate all recombinant DNA research conducted in 
California. In New York, the State Attorney General's Environmental Health 
Bureau has held Hearings and has proposed a bill providing for: adherence 
to safety standards regardless of the source of funding of the prolect; 
certification of researchers by state health officials; inspection of 
facilities by state health officials; creation of institutional biohazards 
committees; submission of periodic reports to state health officials; and, 
medical surveillance of laboratory personnel. 
In addition, Cambridge, Princeton, and other municipalities have formed 
advisory groups. 
[ 253 ] 
